MML Investors Services
NVO

MML Investors Services’s Novo Nordisk NVO Stock Holding History

MML Investors Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45M Buy
197,109
+36,455
+23% +$1.57M 0.02% 659
2026
Q1 		$5.9M Sell
160,654
-28,356
-15% -$1.34M 0.02% 738
2025
Q4 		$9.62M Sell
189,010
-41,132
-18% -$2.1M 0.02% 605
2025
Q3 		$12.8M Sell
230,142
-17,719
-7% -$1.04M 0.03% 469
2025
Q2 		$17.1M Sell
247,861
-33,826
-12% -$2.3M 0.05% 367
2025
Q1 		$19.6M Buy
281,687
+7,457
+3% +$616K 0.07% 304
2024
Q4 		$23.6M Buy
274,230
+4,983
+2% +$539K 0.08% 244
2024
Q3 		$32.1M Buy
269,247
+9,376
+4% +$1.25M 0.12% 185
2024
Q2 		$37.1M Sell
259,871
-27,080
-9% -$3.59M 0.15% 149
2024
Q1 		$36.8M Buy
286,951
+15,657
+6% +$1.86M 0.15% 151
2023
Q4 		$28.1M Buy
271,294
+33,924
+14% +$3.35M 0.13% 179
2023
Q3 		$21.6M Buy
237,370
+4,548
+2% +$401K 0.12% 186
2023
Q2 		$18.8M Buy
232,822
+44,748
+24% +$3.66M 0.1% 206
2023
Q1 		$15M Sell
188,074
-7,570
-4% -$537K 0.11% 213
2022
Q4 		$13.2M Buy
195,644
+14,352
+8% +$841K 0.09% 252
2022
Q3 		$9.03M Buy
181,292
+13,510
+8% +$724K 0.07% 276
2022
Q2 		$9.35M Buy
167,782
+49,714
+42% +$2.76M 0.07% 273
2022
Q1 		$6.56M Buy
118,068
+32,192
+37% +$1.65M 0.05% 366
2021
Q4 		$4.81M Buy
85,876
+5,018
+6% +$272K 0.03% 454
2021
Q3 		$3.88M Buy
80,858
+7,176
+10% +$347K 0.03% 491
2021
Q2 		$3.09M Sell
73,682
-1,380
-2% -$53.5K 0.03% 543
2021
Q1 		$2.53M Sell
75,062
-7,028
-9% -$250K 0.02% 571
2020
Q4 		$2.87M Buy
82,090
+4,740
+6% +$164K 0.03% 462
2020
Q3 		$2.69M Buy
77,350
+8,982
+13% +$299K 0.03% 427
2020
Q2 		$2.24M Buy
68,368
+20,724
+43% +$661K 0.03% 457
2020
Q1 		$1.43M Buy
47,644
+12,088
+34% +$360K 0.02% 507
2019
Q4 		$1.03M Buy
35,556
+5,988
+20% +$166K 0.01% 710
2019
Q3 		$764K Sell
29,568
-8,278
-22% -$209K 0.01% 781
2019
Q2 		$966K Buy
37,846
+890
+2% +$22K 0.01% 732
2019
Q1 		$967K Buy
36,956
+2,258
+7% +$55.5K 0.02% 714
2018
Q4 		$799K Buy
34,698
+1,244
+4% +$27.6K 0.01% 705
2018
Q3 		$788K Buy
33,454
+16,386
+96% +$400K 0.01% 776
2018
Q2 		$394K Buy
17,068
+5,186
+44% +$123K 0.01% 953
2018
Q1 		$293K Sell
11,882
-20,250
-63% -$532K 0.01% 1090
2017
Q4 		$862K Buy
32,132
+1,838
+6% +$46.7K 0.02% 602
2017
Q3 		$729K Buy
30,294
+1,780
+6% +$40.2K 0.02% 620
2017
Q2 		$611K Sell
28,514
-2,360
-8% -$47.6K 0.01% 697
2017
Q1 		$529K Buy
+30,874
New +$538K 0.01% 434

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

MML Investors Services's NVO Position: Q2 2026 in Review

MML Investors Services increased its Novo Nordisk (NVO) stake by 23% in Q2 2026, buying an estimated $1.57M and bringing the position to 197,109 shares worth $9.45M. The position accounts for 0.02% of the portfolio, ranked #659.

MML Investors Services first reported a position in NVO in Q1 2017 and has held it in 38 quarters since. The position peaked at $37.1M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • MML Investors Services held 197,109 shares of Novo Nordisk worth $9.45M as of Q2 2026.
  • MML Investors Services bought 36,455 Novo Nordisk shares in Q2 2026, an estimated $1.57M.
  • Novo Nordisk made up 0.02% of MML Investors Services's portfolio in Q2 2026, its #659 holding.
  • MML Investors Services first reported a position in Novo Nordisk in Q1 2017 and has held it in 38 quarters since.
  • MML Investors Services's Novo Nordisk position peaked at $37.1M in Q2 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.